Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopal Badlani

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
Urology|August 13, 2023
Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical OutcomesIman Sadri, Anindyo Chakraborty, David-Dan Nguyen, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 27, 2015
Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patientsJean de la Rosette, Mostafa Elhilali, Seiji Naito, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
Urology|August 13, 2023
Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical OutcomesIman Sadri, Anindyo Chakraborty, David-Dan Nguyen, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 27, 2015
Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patientsJean de la Rosette, Mostafa Elhilali, Seiji Naito, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Pageof 9